Literature DB >> 25571327

Designing auditory cues for Parkinson's disease gait rehabilitation.

Jorge Cancela, Eugenio M Moreno, Maria T Arredondo, Paolo Bonato.   

Abstract

Recent works have proved that Parkinson's disease (PD) patients can be largely benefit by performing rehabilitation exercises based on audio cueing and music therapy. Specially, gait can benefit from repetitive sessions of exercises using auditory cues. Nevertheless, all the experiments are based on the use of a metronome as auditory stimuli. Within this work, Human-Computer Interaction methodologies have been used to design new cues that could benefit the long-term engagement of PD patients in these repetitive routines. The study has been also extended to commercial music and musical pieces by analyzing features and characteristics that could benefit the engagement of PD patients to rehabilitation tasks.

Entities:  

Mesh:

Year:  2014        PMID: 25571327     DOI: 10.1109/EMBC.2014.6944959

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  4 in total

Review 1.  Music Therapy and Music-Based Interventions for Movement Disorders.

Authors:  Kerry Devlin; Jumana T Alshaikh; Alexander Pantelyat
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

2.  The feasibility of singing to improve gait in Parkinson disease.

Authors:  Elinor C Harrison; Marie E McNeely; Gammon M Earhart
Journal:  Gait Posture       Date:  2017-02-14       Impact factor: 2.840

3.  Therapeutic benefits of music-based synchronous finger tapping in Parkinson's disease-an fNIRS study protocol for randomized controlled trial in Dalian, China.

Authors:  Lanlan Pu; Nauman Khalid Qureshi; Joanne Ly; Bingwei Zhang; Fengyu Cong; William C Tang; Zhanhua Liang
Journal:  Trials       Date:  2020-10-16       Impact factor: 2.279

4.  Beyond the Metronome: Auditory Events and Music May Afford More than Just Interval Durations as Gait Cues in Parkinson's Disease.

Authors:  Matthew W M Rodger; Cathy M Craig
Journal:  Front Neurosci       Date:  2016-06-14       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.